The metabolism of triazene antitumor drugs
- 1 January 1987
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 32 (2) , 191-205
- https://doi.org/10.1016/0163-7258(87)90059-3
Abstract
No abstract availableThis publication has 46 references indexed in Scilit:
- Structural studies on bio-active compounds. Part 5. Synthesis and properties of 2,4-diaminopyrimidine dihydrofolate reductase inhibitors bearing lipophilic azido groupsJournal of the Chemical Society, Perkin Transactions 1, 1986
- Plasma and tissue disposition of mitozolomide in miceBritish Journal of Cancer, 1986
- Triazene drug metabolites: base catalysed formation of n-alkyltriazenes from n-hydroxymethyl-n-alkyltriazenesTetrahedron Letters, 1985
- Metabolism of the anticancer agent 1-(4-acetylphenyl)-3,3-dimethyltriazeneJournal of Mass Spectrometry, 1983
- Studies of the mode of action of antitumour triazenes and triazines—IV. The metabolism of 1-(4-acetylphenyl)-3,3-dimethyltriazeneBiochemical Pharmacology, 1982
- Pharmacokinetics of dacarbazine (DTIC) and its metabolite 5-aminoimidazole-4-carboxamide (AIC) following different dose schedulesCancer Chemotherapy and Pharmacology, 1982
- Tumour inhibitory triazenes: Structural requirements for an active metaboliteBiochemical Pharmacology, 1976
- Studies on the mechanism of action of the tumour inhibitory triazenesBiochemical Pharmacology, 1973
- Specific Carcinogenic and Teratogenic Effects of ‘Indirect’ Alkylating Methyl and Ethyl compounds, and their Dependency on Stages of Ontogenic DevelopmentsXenobiotica, 1973
- Single crystal studies of chemotherapeutic agents. I. Structure of 1-(2-chloroethyl)-3-(5-carbamoylimidazol-4-yl)-.DELTA.2-1,2,3-triazolinium chlorideJournal of Medicinal Chemistry, 1969